Skip to content

Variants with pathogenic/likely pathogenic disease associations

This criterion enables data from external sources to be used to prioritise variants with known pathogenic/likely pathogenic associations that would not otherwise be prioritised. This also enables variants that do not occur in transcripts with a considered biotype (see Criterion 3) to be prioritised.

The population frequency filter (Criterion 2) or predicted functional impact filter (Criterion 3) may result in potentially diagnostic variants with known pathogenic/likely pathogenic associations not being prioritised, e.g. if they are known to be pathogenic but above allele frequency threshold used during variant tiering.

ClinVar

ClinVar aggregates information about genomic variation and its relationship to human health. An individual submission to ClinVar asserting a relationship between a variant and condition are represented by a SCV record. All submissions about the same variant are aggregated into a VCV record.

A variant passes Criterion 6 if:

  1. The variant, or a variant with the same HGVSp as the variant, has a VCV record with a clinical significance that is one of:

    • Pathogenic
    • Likely pathogenic
    • Conflicting interpretations of pathogenicity
  2. The variant, or a variant with the same HGVSp as the variant1, has a VCV record with review status that is one of

    • Practice guideline
    • Reviewed by expert panel
    • Criteria provided, multiple submitters, no conflicts
    • Criteria provided, conflicting interpretations2
    • Criteria provided, single submitter
    • No assertion criteria provided
  3. The variant must have a population frequency in the custom Genomics England frequencies dataset less than 0.05 (i.e. 5%)

Clinical Variant Ark (CVA)

CVA is a Genomics England database which stores information assigned to genomic variants for samples processed by Genomics England bioinformatics pipelines, including:

  • variant classifications
  • variant interpretation logs
  • tiered variants
  • clinical indications upon referral
  • data reported in outcome questionnaires and summary of findings

Details of all the information available are further elaborated on the CVA online help page

A variant passes Criterion 6 if:

  1. The variant has at least one pathogenic or likely pathogenic classification in CVA at the time of interpretation, or

  2. A variant with the same protein change, based on HGVSp annotation for the same transcript, has at least one pathogenic or likely pathogenic classification in CVA at the time of interpretation

  3. The variant must have a population frequency in the custom Genomics England frequencies dataset less than 0.05 (i.e. 5%)

Note

HGVSp annotations are only available for variants classified in cases run following the NGIS Izar release in March 2023

Note

Queries against the CVA database are done in real-time at the time of analysis; CVA is updated daily, therefore reanalysis at a later date can produce different results.

Note

Variant classifications in CVA are continually updated as GMS referrals are reviewed and findings returned. A variant with no pathogenic or likely pathogenic classifications in CVA at the point of interpretation will not pass criterion 6 for CVA even if the variant is subsequently classified as pathogenic or likely pathogenic before being reviewed. However, the variant will display the current CVA classification in the Interpretation Portal.


  1. Variants matched through exact (#1) or protein-matched (#2) logic will be displayed in the same way in the interpretation portal. Users must manually review these events to determine if they were prioritised through the known pathogenic tiering criterion by exact match or through protein-matching. 

  2. Variants with a review status of “criteria provided, conflicting interpretations” must have at least one associated SCV record with a pathogenic/likely pathogenic assertion.